Latest Blogs

Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Jun 19, 2019
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
Jun 11, 2019
I am excited about the entire Breakthrough program, including a session I am leading on the impact of social media and telehealth on cancer care.
Jun 11, 2019
Real actions that promote women and under-represented groups in medicine are doable, starting today.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former Chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for Social Media. He serves on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Dec 03, 2014
Using hashtag analytics, Dr. Matthew Katz presents Twitter data for ASCO and ASTRO Annual Meetings from 2012 through 2014. The findings show that the growth trend continues for sharing research and specialty-specific information in cancer care via social media.
Oct 28, 2014
From everything you read, social media is becoming an increasingly important way to communicate in health care. ASCO has clearly embraced it. Dr. Don Dizon recently wrote a great piece about the...
Aug 30, 2014
Just a little over year ago, I suggested, on ASCO Connection, that those involved in cancer care should start using a set of disease-based hashtags to help patients,...
Jun 02, 2014
It’s been almost three years since the National Lung Screening Trial (NLST) reported a 20% reduction in lung cancer mortality. Why is it taking so long to see low-dose CT screening become a reality?
May 02, 2014
The countdown to the Annual Meeting is underway. In one month, ASCO members converge on Chicago to learn about the latest peer-reviewed advances in oncology. For attendees, it can be overwhelming but is a great opportunity for learning, networking, and seeing what may be coming soon to your cancer...
Apr 10, 2014
Increasingly, cancer care is becoming more evidence-based and personalized. But there are still a lot of areas where we need to question the conventional wisdom. How much of what we learned during training is based upon evidence versus anecdote and assumption?

Pages